<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Hepatitis B</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Hepatitis B.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/hepatitis-b.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Hepatitis B and C Prevention, Screening, and Diagnostic Services at HIV Treatment Sites: International Epidemiology Databases to Evaluate AIDS.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-qai-0000000000003896-a601496f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-qai-0000000000003896-a601496f/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Findings point to gaps in HBV and HCV service availability at HIV treatment sites, particularly rural sites, relevant to efforts to address these infections among people receiving HIV care.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>AIDS</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Functionally cured chronic hepatitis B: A cure‐related occult HBV infection state</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-mlf2-70102-c24dd73a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-mlf2-70102-c24dd73a/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>Maintaining blood supply integrity and establishing standardized post-treatment monitoring pathways are essential to address residual transmissibility in clinically resolved cases.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Seroprevalence, associated factors, and molecular detection of hepatitis B virus co-infection among HIV-positive adults in Okene, Nigeria</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-31989-dsn-v5i8-2066-26506a4f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-31989-dsn-v5i8-2066-26506a4f/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The measured infection frequency indicates a persistent dual-viral burden within this regional healthcare setting, reinforcing the value of systematic diagnostic protocols and immunization initiatives.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>AIDS</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4254-wjh-124108-0496c536/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4254-wjh-124108-0496c536/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest acute HBV infection in the vaccination era carries higher-than-expected chronicity risk, particularly among patients with metabolic disease and socioeconomic disadvantage. This supports the need for early risk stratification and targeted follow-up for vulnerable populations despite vaccine availability.</description>
    <category>Acute hepatitis B</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Hepatitis B in Organ Transplantation-Current Evidence and Clinical Gaps.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-tid-70299-d8ebbf59/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-tid-70299-d8ebbf59/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>By addressing a viral infection affecting hundreds of millions globally, the review highlights how optimized antiviral protocols and broader donor eligibility can enhance transplant system capacity and patient survival.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in USA and Puerto Rico: Results from a Phase III, randomized, active-controlled study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-21645515-2026-2716508-f8e301e4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-21645515-2026-2716508-f8e301e4/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Establishing the safety of this vaccine when combined with routine pediatric immunizations aids regulatory approval and clinical administration guidelines. The data contributes to understanding potential interactions within standard infant vaccination protocols.</description>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Pertussis</category>
    <category>Meningococcal disease</category>
    <category>Varicella</category>
    <category>Hepatitis B</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Hepatitis B Immunization Among Healthcare Students: A Narrative Review of Occupational Risk, Seroprotection, and Immunization Management</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14090732-18f977c3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14090732-18f977c3/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The abstract identifies healthcare-student HBV exposure, incomplete vaccination documentation, heterogeneous schedules, and variable institutional protocols as occupational-health and prevention concerns. It describes pre-clinical serological assessment and structured immunization management as operational approaches discussed by the review.</description>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Pradefovir mesylate and tenofovir amibufenamide for chronic hepatitis B: a systematic review and pragmatic treatment algorithm</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fphar-2026-1862886-7d080baa/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fphar-2026-1862886-7d080baa/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The manuscript consolidates comparative safety and efficacy data to inform clinical guidelines regarding newly approved nucleotide prodrugs for chronic hepatitis B management.</description>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>The Level of Knowledge, Attitude, Practice, and Adherence of Obstetricians and Gynecologists Towards the Triple Elimination Program (HIV, Syphilis, Hepatitis B) in Maternal Services at Government and Private Hospitals in Jakarta</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-ijerph23081090-faea2511/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-ijerph23081090-faea2511/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings point to gaps in provider knowledge, attitudes, practice, and adherence related to a program aimed at reducing mother-to-child transmission of HIV, syphilis, and hepatitis B, underscoring the need for targeted improvement efforts in maternal services.</description>
    <category>Hepatitis B</category>
    <category>Syphilis</category>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Clinically Relevant Risk of Hepatitis B Virus Infection and Reactivation in People with HIV After Withdrawal of Anti-HBV–Active Antiretroviral Therapy in Japan</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag533-2c8321c6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag533-2c8321c6/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>The data underscore potential vulnerabilities in viral containment when standard prophylactic medication elements are removed from ongoing care plans. These observations may assist health authorities in refining monitoring protocols for patient populations transitioning between therapeutic strategies in areas where population-level immunization coverage remains incomplete.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>HBsAg glycan isomer: a potential circulating biomarker for monitoring cccDNA and predicting virologic response in chronic hepatitis B</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1818958-aa058eb2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1818958-aa058eb2/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>If validated, HBsAgGi could offer a minimally invasive serum indicator of intrahepatic cccDNA activity and a tool for monitoring antiviral response in chronic hepatitis B, which is relevant to treatment management in affected populations.</description>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Drug resistance mutations of hepatitis B virus (HBV) influence the yield of the virions of the human hepatitis delta virus (HDV) and their infectivity</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00610-26-8087d0b4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00610-26-8087d0b4/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest that hepatitis B drug resistance mutations may suppress HDV superinfection and reduce the HDV reservoir in infected livers, potentially limiting chronic HDV infection and associated liver pathology when resistance mutations predominate on HBsAg molecules.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Dynamics on Hepatitis B Virus Infection In Vivo with Immune Noise and Interval Delay</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1137-25m1809446-163d5561/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1137-25m1809446-163d5561/</guid>
    <pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate>
    <description>The model contributes to understanding variability in immune-mediated HBV infection trajectories and may inform interpretation of clinical fluctuations in viral load, though translation to intervention or surveillance requires empirical validation.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Serologic Immunity to Hepatitis A and B in US Adults and High-Risk Populations</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1001-jamainternmed-2026-3831-dca77f2e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1001-jamainternmed-2026-3831-dca77f2e/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>Widespread susceptibility across multiple demographic and clinical strata suggests current immunization coverage falls short of optimal population thresholds. These results emphasize the necessity for focused preventive campaigns directed toward underserved and medically vulnerable communities.</description>
    <category>Hepatitis A</category>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Africa’s Silent Humanitarian Crisis: Why Viral Hepatitis Must No Longer Be Ignored</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-rescon-vmag135-8768e99e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-rescon-vmag135-8768e99e/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article positions viral hepatitis as an urgent public health priority warranting immediate action through expanded testing, diagnosis, treatment, birth-dose vaccination, and integration with Universal Health Coverage initiatives.</description>
    <category>Viral Hepatitis</category>
    <category>Malaria</category>
    <category>Chronic hepatitis B</category>
    <category>Tuberculosis</category>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Hepatitis B and D burden in Uzbekistan: comprehensive analysis of seroprevalence and risk correlates from a countrywide study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01487-w-d43eb4b6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01487-w-d43eb4b6/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The persistent infection rates and localized disease clusters indicate a need for region-specific control strategies and expanded vaccination coverage for older cohorts. Identifying household contact practices as a transmission driver offers a practical avenue for community-based prevention initiatives.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Molecular Characterization and Genotypic Distribution of Hepatitis B Virus Isolates in Iraq: Prevalence of Drug Resistance Mutations</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-21123-2411-7986-5379-bc7237f3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-21123-2411-7986-5379-bc7237f3/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings highlight substantial antiviral resistance among circulating HBV strains in Iraq and underscore the need for continuous surveillance to guide treatment strategies. This is reported as the first local study correlating genotypic variation with drug resistance in this setting.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Global stability of two-patch within-host HBV infection dynamics with unidirectional viral spread</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-28924-2291-8639-24-2026-257-d7074e98/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-28924-2291-8639-24-2026-257-d7074e98/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings may provide mathematical context for understanding factors related to persistence of HBV within the modelled host environment. The supplied article does not report patient outcomes, population-level effects, or an evaluation of public health interventions.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>Transmission dynamics</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Hepatic Artery Doppler Haemodynamic Indices as Imaging Biomarkers of Disease Activity in Adults with Chronic Hepatitis B: Correlation with Viral Load and Serum Alanine Transaminase</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4103-npmj-npmj-141-26-d8b6a40c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4103-npmj-npmj-141-26-d8b6a40c/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support further consideration of hepatic artery Doppler measurements as non-invasive markers of hepatic vascular changes or disease-related laboratory abnormalities in asymptomatic adults with chronic hepatitis B. The supplied article does not establish effects on patient outcomes, transmission, or population-level disease control.</description>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Clinical progress note: Hepatitis B</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-jhm-70424-fafda04a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-jhm-70424-fafda04a/</guid>
    <pubDate>Sat, 15 Aug 2026 00:00:00 GMT</pubDate>
    <description>Shifting national immunization directives and growing vaccine reluctance emphasize the sustained requirement for vigilant epidemiological tracking and targeted pediatric intervention strategies.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Seroprevalence of hepatitis D among hepatitis B-infected patients attending the viral hepatitis treatment unit in Alexandria, Egypt: a prospective cross-sectional observational study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13956-6-eb913973/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13956-6-eb913973/</guid>
    <pubDate>Fri, 14 Aug 2026 00:00:00 GMT</pubDate>
    <description>The observed exposure frequency underscores a notable co-infection burden within this regional hepatitis B population, indicating that routine diagnostic evaluation could enhance case identification in comparable healthcare environments.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis A</category>
    <category>Treatment</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Vaccination policies for healthcare personnel in Europe, 2026</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128839-f5b67b79/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128839-f5b67b79/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings highlight persistent variation in healthcare worker vaccination policies across Europe despite recent expansion. The authors note that harmonized, evidence-based policies are needed to protect both healthcare personnel and patients amid resurgence of vaccine-preventable diseases.</description>
    <category>COVID-19</category>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Influenza</category>
    <category>Tetanus</category>
    <category>Zoster</category>
    <category>Hepatitis A</category>
    <category>Tuberculosis</category>
    <category>Mumps</category>
    <category>Rubella</category>
    <category>Varicella</category>
    <category>Hepatitis B</category>
    <category>Poliomyelitis</category>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Prioritizing the introduction of new vaccine in Tanzania (2026–2030): a multi-criteria decision analysis by the Tanzania immunization technical advisory group</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128985-3837733d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128985-3837733d/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The documented scoring mechanism enables resource-limited jurisdictions to conduct systematic, transparent evaluations when expanding routine immunization programs.</description>
    <category>Hepatitis B</category>
    <category>Malaria</category>
    <category>Typhoid fever</category>
    <category>Mumps</category>
    <category>Rubella</category>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Efficacy and safety of TDF+3TC + EFV‑centric antiretroviral regimens for HIV/HBV co-infection: a systematic review and network meta‑analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13806-5-fad0a9c9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13806-5-fad0a9c9/</guid>
    <pubDate>Sat, 13 Jun 2026 00:00:00 GMT</pubDate>
    <description>The review provides comparative treatment evidence concerning virologic outcomes, CD4+ lymphocyte counts, and reported safety outcomes in people with HIV/HBV co-infection. Its findings may support editorial understanding of the treatment-evidence literature, but the supplied abstract does not establish effectiveness in a broader population or provide implementation, access, or outcome data outside the included trials.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Global burden and forecast of acute viral hepatitis B among women of childbearing age: a systematic analysis of the global burden of disease study 2021.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13302-w-894581b6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13302-w-894581b6/</guid>
    <pubDate>Sat, 16 May 2026 00:00:00 GMT</pubDate>
    <description>These epidemiological insights assist policymakers in designing region-targeted intervention frameworks and support broader international objectives for viral hepatitis management. The results emphasize the continued importance of sustaining immunization programs, enforcing sterile medical practices, and delivering effective maternal transmission safeguards.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Acute hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Sex-specific burdens of acute hepatitis B and C and their attributable risk factors in 204 countries and territories, 1990-2021.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-00942-6-900f1df6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-00942-6-900f1df6/</guid>
    <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
    <description>Ongoing demographic and geographic inequalities emphasize the importance of customized intervention approaches, such as enhanced immunization campaigns, expanded diagnostic testing, improved therapeutic access, and risk reduction measures to align with international elimination targets.</description>
    <category>Hepatitis C</category>
    <category>Acute hepatitis B</category>
    <category>Hepatitis B</category>
    <category>Acute hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Viral Hepatitis</category>
    <category>COVID-19</category>
    <category>Climate and environment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Association between fatty liver and risk of liver failure in patients with acute hepatitis B: a retrospective cohort study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1712115-7b1cb92c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1712115-7b1cb92c/</guid>
    <pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate>
    <description>These observational data highlight how metabolic comorbidities intersect with viral hepatitis trajectories, providing contextual information for epidemiological tracking and early risk stratification frameworks.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Acute hepatitis B</category>
    <category>Treatment</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>[Trends and Epidemiological Characteristics of Acute Hepatitis B among Foreign Nationals in the Republic of Korea, 2014-2024].</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-56786-phwr-2025-18-44-1-5a38d3b8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-56786-phwr-2025-18-44-1-5a38d3b8/</guid>
    <pubDate>Mon, 20 Oct 2025 00:00:00 GMT</pubDate>
    <description>The rising influx of international residents highlights the necessity for targeted disease control initiatives within the host country. Identifying gaps in immunization documentation and addressing potential barriers to medical access can inform more effective community-based prevention programs.</description>
    <category>Acute hepatitis B</category>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Travel medicine</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Use of Haemophilus influenzae Type b–Containing Vaccines Among American Indian and Alaska Native Infants: Updated Recommendations of the Advisory Committee on Immunization Practices ― United States, 2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7336a4-a64084d7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7336a4-a64084d7/</guid>
    <pubDate>Thu, 12 Sep 2024 00:00:00 GMT</pubDate>
    <description>The guideline addresses a health disparity by offering AI/AN communities an additional vaccine option that maintains early protection against invasive Hib disease while simplifying infant immunization schedules through a combination vaccine. It may improve vaccine uptake and coverage in a high-risk population.</description>
    <category>Haemophilus influenzae</category>
    <category>Influenza</category>
    <category>Hepatitis B</category>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2023</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7333a1-f30b4d9a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7333a1-f30b4d9a/</guid>
    <pubDate>Thu, 22 Aug 2024 00:00:00 GMT</pubDate>
    <description>Findings highlight the need for providers to deliver strong vaccine recommendations and verify adolescent vaccination status to maintain protection against vaccine-preventable diseases.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Differences between males and females in infectious diseases notifications in the EU/EEA, 2012 to 2021</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-33-2300655-91c183b8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-33-2300655-91c183b8/</guid>
    <pubDate>Thu, 15 Aug 2024 00:00:00 GMT</pubDate>
    <description>The paper is relevant to surveillance review because it summarizes sex-pattern differences in reported infectious diseases across the EU/EEA. It also notes that behavior may contribute for some infections and that screening practices may help explain country differences, but these are presented as interpretations rather than confirmed effects.</description>
    <category>COVID-19</category>
    <category>Malaria</category>
    <category>Chlamydia trachomatis infection</category>
    <category>Hepatitis B</category>
    <category>Listeriosis</category>
    <category>Acute hepatitis B</category>
    <category>Pertussis</category>
    <category>AIDS</category>
    <category>Campylobacteriosis</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Restoration of a functional antiviral immune response to chronic HBV infection by reducing viral antigen load: if not sufficient, is it necessary?</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2021-1952851-82959ab5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2021-1952851-82959ab5/</guid>
    <pubDate>Sat, 07 Aug 2021 00:00:00 GMT</pubDate>
    <description>Discussions focus on developing therapies to achieve durable control of the infection, described as a functional cure, for most treated patients.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Chronic hepatitis B</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>High impact of molecular surveillance on hepatitis A outbreak case detection in Sweden: a retrospective study, 2009 to 2018</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2021-26-9-1900763-51795d14/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2021-26-9-1900763-51795d14/</guid>
    <pubDate>Thu, 04 Mar 2021 00:00:00 GMT</pubDate>
    <description>This paper is relevant to genomic epidemiology and outbreak investigation because it describes the use of sequence-based typing in Swedish hepatitis A surveillance. It provides literature context on how molecular data can help organize cluster detection work.</description>
    <category>Hepatitis A</category>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41541-020-00266-4-cdac0d00/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41541-020-00266-4-cdac0d00/</guid>
    <pubDate>Mon, 11 Jan 2021 00:00:00 GMT</pubDate>
    <description>The findings suggest that obese individuals with NAFLD may have suboptimal immune responses to standard hepatitis B vaccination, potentially requiring modified vaccination strategies or monitoring in this population.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Hepatitis A</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2471-blt-19-248146-d33c5088/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2471-blt-19-248146-d33c5088/</guid>
    <pubDate>Wed, 28 Oct 2020 00:00:00 GMT</pubDate>
    <description>The findings demonstrate how national surveillance data combined with modeling can guide elimination efforts and may motivate other high-burden countries to strengthen hepatitis B prevention policies. The study identifies specific, measurable intervention strategies to accelerate progress toward WHO elimination targets.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Hepatitis A</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Multiple Introductions of Domestic Cat Feline Leukemia Virus in Endangered Florida Panthers1</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2501-181347-ca726886/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2501-181347-ca726886/</guid>
    <pubDate>Tue, 01 Jan 2019 00:00:00 GMT</pubDate>
    <description>The detection of multiple FeLV strains and an oncogenic recombinant in an endangered species indicates ongoing high risk for FeLV infection in Florida panthers despite prior vaccination efforts, with implications for wildlife conservation and domestic cat reservoir management.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Hepatitis A Virus Outbreaks Associated with Drug Use and Homelessness — California, Kentucky, Michigan, and Utah, 2017</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6743a3-37729b47/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6743a3-37729b47/</guid>
    <pubDate>Fri, 02 Nov 2018 00:00:00 GMT</pubDate>
    <description>Vaccination of high-risk populations reporting drug use or homelessness can prevent future HAV outbreaks involving direct person-to-person transmission.</description>
    <category>Hepatitis A</category>
    <category>Gastroenteritis</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2018-01-065-bc387b6f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2018-01-065-bc387b6f/</guid>
    <pubDate>Thu, 01 Mar 2018 00:00:00 GMT</pubDate>
    <description>The authors frame universal vaccination programs as a highly effective prevention tool and emphasize that health authorities should reinforce public confidence in vaccines by communicating the scientific evidence of their benefits.</description>
    <category>Measles</category>
    <category>Diphtheria</category>
    <category>Rubella</category>
    <category>Poliomyelitis</category>
    <category>Mumps</category>
    <category>Hepatitis B</category>
    <category>Pertussis</category>
    <category>Meningococcal disease</category>
    <category>Tetanus</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2017-06-023-93ef9dd1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2017-06-023-93ef9dd1/</guid>
    <pubDate>Fri, 01 Dec 2017 00:00:00 GMT</pubDate>
    <description>The recommendations address prevention and management of HBV reactivation, which is associated with high morbidity and mortality in haematologic patients, and provide vaccination guidance applicable across this immunocompromised population.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2305-161477-d21f5459/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2305-161477-d21f5459/</guid>
    <pubDate>Mon, 01 May 2017 00:00:00 GMT</pubDate>
    <description>China&apos;s perinatal transmission-targeted HBV prevention program has been highly successful and increasingly effective. Sustained effort over decades and augmented strategies will be needed to eliminate HBV transmission.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Chronic hepatitis B</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Requirements for global elimination of hepatitis B: a modelling study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-16-30204-3-6fe3eb84/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-16-30204-3-6fe3eb84/</guid>
    <pubDate>Thu, 01 Dec 2016 00:00:00 GMT</pubDate>
    <description>Expanding preventive and therapeutic initiatives supports international health frameworks designed to minimize viral transmission and decrease disease-associated mortality globally.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Completion of the entire hepatitis C virus life cycle in genetically humanized mice</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-nature12427-7ce1c442/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-nature12427-7ce1c442/</guid>
    <pubDate>Wed, 31 Jul 2013 00:00:00 GMT</pubDate>
    <description>The model provides a preclinical platform for testing antiviral drug candidates and may support vaccine efficacy evaluation for a pathogen affecting over 130 million people globally.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-ese-17-22-20183-en-1c0d334e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-ese-17-22-20183-en-1c0d334e/</guid>
    <pubDate>Thu, 31 May 2012 00:00:00 GMT</pubDate>
    <description>The findings provide comparative information about European vaccination strategies, suggesting that understanding diverse approaches may help countries adapt their programmes. High compliance has been achieved in many European programmes using only recommendations rather than mandates.</description>
    <category>Influenza</category>
    <category>Gastroenteritis</category>
    <category>Poliomyelitis</category>
    <category>Hepatitis B</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Climate and environment</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Preventing and Controlling Emerging and Reemerging Transmissible Diseases in the Homeless</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid1409-080204-7cbfd473/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid1409-080204-7cbfd473/</guid>
    <pubDate>Mon, 01 Sep 2008 00:00:00 GMT</pubDate>
    <description>Homelessness is described as an increasing public health problem, and the authors call for national public health programs specifically addressing homeless populations.</description>
    <category>Tuberculosis</category>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Hepatitis D</category>
    <category>Diphtheria</category>
    <category>Influenza</category>
    <category>Hepatitis A</category>
    <category>One Health</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Major Outbreak of Hepatitis A Associated with Orange Juice among Tourists, Egypt, 2004</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid1301-060487-22c1f60a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid1301-060487-22c1f60a/</guid>
    <pubDate>Mon, 01 Jan 2007 00:00:00 GMT</pubDate>
    <description>The abstract frames the outbreak as travel-associated hepatitis A and states that hepatitis A vaccination is recommended before travel to endemic areas. This is relevant to travel medicine and outbreak prevention messaging.</description>
    <category>Hepatitis A</category>
    <category>Gastroenteritis</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis A outbreak among methamphetamine drug users</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2004-07-038-c17c9043/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2004-07-038-c17c9043/</guid>
    <pubDate>Sat, 01 Jan 2005 00:00:00 GMT</pubDate>
    <description>In communities where illicit drug users face hepatitis A risk and are frequently incarcerated, jail-based vaccination programs may serve as an important component of outbreak control strategies.</description>
    <category>Hepatitis A</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1017-s0950268898001411-0f91556f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1017-s0950268898001411-0f91556f/</guid>
    <pubDate>Thu, 01 Oct 1998 00:00:00 GMT</pubDate>
    <description>The findings suggest hepatitis A vaccination without immunoglobulin may be a viable outbreak control measure in institutional settings. The study also indicates increasing susceptibility to hepatitis A virus in central Italy over recent decades.</description>
    <category>Hepatitis A</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Gastroenteritis</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
